• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROMODULATION ACTIVA; IMPLANTED SUBCORTICAL ELECTRICAL STIMULATOR (MOTOR DISORDERS)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROMODULATION ACTIVA; IMPLANTED SUBCORTICAL ELECTRICAL STIMULATOR (MOTOR DISORDERS) Back to Search Results
Model Number 3387
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Unspecified Infection (1930); Neurological Deficit/Dysfunction (1982); Pain (1994); Complaint, Ill-Defined (2331)
Event Date 10/20/2015
Event Type  Injury  
Manufacturer Narrative
It was not possible to ascertain specific device information from the article or to match the events reported with previously reported events.Correspondence has been sent to the author of the article inquiring about patient and device information and additional information regarding the reported events.(b)(4).
 
Event Description
Krause, p., bruggemann, n., volzmann, s., horn, a., kupsch, a., schneider, g.H., lohmann, k., kuhn, a.Long-term effect on dystonia after pallidal deep brain stimulation (dbs) in three members of a family with a thap1 mutation.Journal of neurology.2015.Doi 1 0.1007/s00415-015-7908-z summary: deep brain stimulation (dbs) of the globus pallidus internus (gpi) is an established treatment in patients with severe dystonia.However, factors predicting outcome are largely unknown and motor improvement in dyt6 patients after dbs has been reported to be poorer as compared to, e.G., dyt1 patients.Here, we report the course of clinical improvement for up to 11 years of pallidal dbs in three male patients belonging to the same family with early-onset generalized or segmental dystonia due to a heterozygous thap1 gene mutation (dyt6).All patients showed an initial effective response to pallidal dbs with a mean of 56.9 ± 11.7 % improvement in the burke¿fahn¿marsden dystonia motor and 45.5 ± 22.4 % in the disability score at 1-year follow-up.The long-term outcome of pallidal dbs was favorable in two patients (39, 67 % motor improvement, respectively).Our findings demonstrate that motor improvement is variable and may depend on disease severity, disease duration, and clinical presentation.Overall, our observation supports pallidal dbs as an important treatment option in patients with dyt6 dystonia.Reported event: it was reported that the patient, who had pallidal deep brain stimulation (dbs) for severe generalized dystonia, had a clinically meaningful response initially, with 70.5% improvement in motor scores and 88.9% improvement in disability scores at the one year follow-up.However, the whole dbs system had to be explanted due to local electrode infection nine years after implantation.Dystonic symptoms, pain, and degree of disability worsened rapidly without dbs, so that bilateral pallidal dbs electrodes were re-implanted soon after successful antibiotic treatment.The source literature included the following device specifics: lead model 3387 and implantable neurostimulators itrel ii or kinetra model 7428 further information has been requested; a supplemental report will be submitted if additional information is received.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACTIVA
Type of Device
IMPLANTED SUBCORTICAL ELECTRICAL STIMULATOR (MOTOR DISORDERS)
Manufacturer (Section D)
MEDTRONIC NEUROMODULATION
800 53rd ave ne
minneapolis MN 55421 1200
Manufacturer (Section G)
MEDTRONIC NEUROMODULATION
7000 central avenue ne rcw215
minneapolis MN 55432
Manufacturer Contact
diane wolf
7000 central avenue ne rcw215
minneapolis, MN 55432
7635263987
MDR Report Key5277363
MDR Text Key33053201
Report Number3007566237-2015-03710
Device Sequence Number1
Product Code MRU
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
H020007
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Health Professional
Type of Report Initial
Report Date 11/12/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/09/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number3387
Device Catalogue Number3387
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/12/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age00029 YR
-
-